Literature DB >> 26266192

The Incidence of Severe Diarrhea with Transdermal Fentanyl Patch: An Uncommon Event.

Karim Hemati1, Poupak Rahim Zadeh2.   

Abstract

Cancer pain is a major problem for the health care providers. One of the most important aspects of cancer pain is palliative care management. Recently, different research finding shows the efficacy of opioid analgesics such as fentanyl transdermal patch in chronic pain management. Transdermal Fentanyl patches may cause side effects such as drowsiness, dizziness, itching, life-threatening or serious breathing difficulties and diarrhea, mainly during the first 72 h of patient's treatment initiation and any time when the drug's dose is increased. We report three case reports of severe diarrhea without most common side effects associated with Fentanyl patches during first 72 h of patient's treatment.

Entities:  

Keywords:  Analgesics cancer; Chemotherapy; Pain

Year:  2015        PMID: 26266192      PMCID: PMC4525582          DOI: 10.7860/JCDR/2015/13194.6024

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

Review 1.  Practical considerations for optimal transdermal drug delivery.

Authors:  Cheryl Durand; Abdullah Alhammad; Kristine C Willett
Journal:  Am J Health Syst Pharm       Date:  2012-01-15       Impact factor: 2.637

Review 2.  Skin tolerability of transdermal patches.

Authors:  Johannes Wohlrab; B Kreft; B Tamke
Journal:  Expert Opin Drug Deliv       Date:  2011-04-21       Impact factor: 6.648

3.  Six- versus 12-h conversion method from intravenous to transdermal fentanyl in chronic cancer pain: a randomized study.

Authors:  Motoo Nomura; Minoru Kamata; Hiroyuki Kojima; Kenji Hayashi; Masasuke Kozai; Satoshi Sawada
Journal:  Support Care Cancer       Date:  2010-06-13       Impact factor: 3.603

4.  High-dose fentanyl patch for cancer pain of a patient with cholangiocarcinoma.

Authors:  Jung Han Kim; Mi Kim; Chong Won Sung; Hyeoung Su Kim; Hyun Joo Jang; Young Chul Shin; Joo Young Jung
Journal:  Korean J Intern Med       Date:  2010-08-31       Impact factor: 2.884

Review 5.  A systematic review of randomized trials on the effectiveness of opioids for cancer pain.

Authors:  Dhanalakshmi Koyyalagunta; Eduardo Bruera; Daneshvari R Solanki; Kent H Nouri; Allen W Burton; Marco Perez Toro; Brian M Bruel; Laxmaiah Manchikanti
Journal:  Pain Physician       Date:  2012-07       Impact factor: 4.965

Review 6.  Psychological approaches to understanding and treating disease-related pain.

Authors:  Francis J Keefe; Amy P Abernethy; Lisa C Campbell
Journal:  Annu Rev Psychol       Date:  2005       Impact factor: 24.137

7.  Evaluation of efficacy and safety of fentanyl transdermal patch (Durogesic D-TRANS) in chronic pain.

Authors:  Jin Hoon Park; Jeoung Hee Kim; Sung Cheol Yun; Sung Woo Roh; Seung Chul Rhim; Chang Jin Kim; Sang Ryong Jeon
Journal:  Acta Neurochir (Wien)       Date:  2010-09-07       Impact factor: 2.216

8.  Pain management.

Authors:  C I Ripamonti
Journal:  Ann Oncol       Date:  2012-09       Impact factor: 32.976

Review 9.  Cancer pain and analgesia.

Authors:  Paul J Christo; Danesh Mazloomdoost
Journal:  Ann N Y Acad Sci       Date:  2008-09       Impact factor: 5.691

10.  Efficacy of fentanyl transdermal patch in the treatment of chronic soft tissue cancer pain.

Authors:  Karim Hemati; Behrooz Zaman; Valliolah Hassani; Farnad Imani; Parviz Dariaie
Journal:  Anesth Pain Med       Date:  2015-02-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.